Used as an intermediate in the synthesis of kinase inhibitors, particularly in the development of anticancer agents. Its structure allows for selective modification of pyrazolopyrimidine-based compounds that target tyrosine kinases involved in cell signaling pathways. Commonly employed in medicinal chemistry for optimizing potency and selectivity in drug candidates. Also utilized in the preparation of labeled derivatives for metabolic and binding studies.